Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,308 total articles
Felix Fernandez, a director at Cathay General Bancorp (NASDAQ: CATY), sold 8,972 shares on January 29, 2026, for $453,444. The bank also reported fourth-quarter fiscal 2025 results that beat expectations on both earnings and revenue and disclosed a planned CFO retirement effective March 1, 2026, with an internal successor named and the outgoing CFO…
Ionis Pharmaceuticals CEO Brett P. Monia sold 29,430 shares on February 6, 2026, for a total of $2.52 million under a Rule 10b5-1 plan. The sale occurred as the stock traded close to its 52-week high and follows a series of clinical, regulatory and commercial developments for the company. InvestingPro flags the shares as overvalued based on Fair Va…
Maureen Hemhauser, EVP and Chief Risk Officer at PEAPACK GLADSTONE FINANCIAL CORP (NASDAQ:PGC), sold 5,272 shares of common stock on February 9, 2026, for a total of $187,604, according to a Form 4 filed with the Securities and Exchange Commission. The filing shows Hemhauser now holds no directly owned shares but retains a variety of indirect and d…
Ashish Bhutani, a director at Ares Management Corp (NYSE: ARES), purchased 10,000 Class A shares on February 6, 2026, for $1.27 million, raising his direct holdings to 34,071 shares. The transaction was disclosed in a Form 4 filed on February 10, 2026. The move comes after Ares reported fourth-quarter 2025 results that missed analyst expectations a…
A director at Sterling Infrastructure sold 4,000 shares across three transactions between February 6 and February 9, 2026, generating $1.61 million in proceeds. The sales were executed under a Rule 10b5-1 trading plan. Sterling shares are trading close to a 52-week high after delivering a 186.6% return over the past year. Separately, the company au…
Director Takata Akira reported the sale of 3,500 shares of SiTime Corp (SITM) common stock on February 6, 2026, via a Form 4 filing with the Securities and Exchange Commission, generating $1,511,055 in proceeds. The director retains 13,734 shares after the sale, including 1,290 unvested restricted stock units. Separately, SiTime disclosed fourth-qu…
Delta Air Lines executive vice president Steven M. Sear disclosed the sale of 38,600 shares of common stock on February 9, 2026, in a Form 4 filing with the Securities and Exchange Commission. The transaction generated $2.9 million in proceeds, with sale prices between $75.020 and $75.125 per share. After the trade, Sear holds 104,404 shares direct…
Glen W. Hauenstein, President of Delta Air Lines, sold 426,933 shares of common stock in transactions executed between February 6 and February 9, 2026, generating $31.3 million. On February 6 he sold 165,864 shares at $71.00 and an additional 123,910 shares at prices between $74.575 and $75.120. On February 9 he sold 137,159 shares at prices betwee…
Peter W. Carter, Delta Air Lines' Chief External Affairs Officer, completed a sale of 27,000 shares on Feb. 6, 2026, generating roughly $2.02 million. The transaction leaves Carter with 421,744 shares. Separately, Delta declared a quarterly dividend and struck a definitive agreement to acquire 31 widebody aircraft from Airbus, while BofA and UBS ma…
Saria Tseng, Executive Vice President and General Counsel of Monolithic Power Systems, sold 22,875 shares on February 6, 2026, for $26.79 million to satisfy tax obligations associated with the vesting of restricted stock units. The transaction, disclosed on a Form 4 with the SEC, leaves Tseng with 200,626 directly held shares and an indirect holdin…
Deming Xiao, Executive Vice President of Global Operations at Monolithic Power Systems Inc (MPWR), sold 22,875 shares on February 6, 2026 for $26,790,369 to satisfy tax obligations tied to released restricted stock units. The trade occurred close to MPWR's 52-week high, while the company reported record Q4 2025 revenue and modestly beat EPS expecta…
Rapid Micro Biosystems Chief Operating Officer John J. Addington sold 4,610 shares of Class A common stock on February 9, 2026, raising roughly $17,438 to meet tax obligations tied to vested restricted stock units. The company, with a market capitalization of $180.8 million, reported robust year-over-year revenue growth for 2025 but is drawing down…
Maurice Sciammas, Executive Vice President of Monolithic Power Systems Inc., executed an open-market sale of 22,875 common shares on February 6, 2026, generating $26,790,369 at an average price of $1,171.1637 per share. The transaction, disclosed by the company, was completed to satisfy tax obligations associated with the release of restricted stoc…
David Bass, Executive Vice President of Engineering and CTO at Varonis Systems Inc (NASDAQ: VRNS), purchased 2,980 shares of company stock on February 9, 2026, at $23.47 per share, for a total of about $69,940. Two days earlier he received 169,095 restricted stock units at no cost. After these events Bass directly owns 1,042,924 Varonis shares. Mea…
Globe Life Inc. director Mark A. Blinn reported the sale of 1,750 shares on February 6, 2026, for $147.91 per share, totaling $258,842. After the sale he directly holds 1,373 shares and indirectly owns 3,372 shares through a trust. Separately, Globe Life's fourth-quarter 2025 results showed earnings per share of $3.39 and revenue of $1.52 billion, …
Chad M. Smith, president and chief operating officer of Better Mortgage at Better Home & Finance Holding Co (NASDAQ:BETR), reported multiple insider transactions in early February 2026 including a sale of Class A shares and the exercise and conversion of equity awards. The activity comes as BETR’s stock has shown wide swings, while the company repo…
Charles Schwab Co-Chairman Walter W. Bettinger sold 67,514 shares of Schwab common stock on February 6, 2026, generating proceeds of $7.04 million at a weighted average price of $104.2521. On the same day he exercised options to buy 67,514 shares at $42.99. The company also announced a 19% increase to its regular quarterly dividend and is undergoin…
ON24 Inc. Chief Financial Officer Steven Vattuone sold 325 shares on February 10, 2026, under a pre-arranged Rule 10b5-1 plan to meet tax-withholding obligations tied to restricted stock unit vesting. The company is simultaneously advancing a definitive agreement to be acquired by Cvent for about $400 million and has secured a U.S. patent for AI te…
Summary: Jeffrey J. LaValle, Vice President, General Counsel, and Secretary of Zurn Elkay Water Solutions Corp (NYSE: ZWS), sold 6,097 shares on February 10, 2026, realizing $315,824 at a weighted average price of $51.80. The sale followed recent equity awards - 18,407 shares vested as performance stock units on February 6 and 2,334 restricted stoc…
Alignment Healthcare Chief Executive Officer John E. Kao sold 180,000 shares on February 10, 2026, for $3.68 million under a pre-arranged trading plan. The transaction occurred as the stock has appreciated strongly over six months and follows positive analyst updates and company membership guidance for 2026.
Alignment Healthcare CHRO Andreas P. Wagner sold 22,238 shares on February 10, 2026, at $20.47 per share to satisfy tax-withholding obligations tied to vested restricted share units. The company is forecasting 24-27% member growth by year-end 2026 and has drawn upward revisions to price targets and ratings from multiple analysts.
Jana Partners Management, LP sold 1,959,221 shares of TreeHouse Foods (THS) on February 10, 2026, for about $47.9 million at a weighted average price of $24.48. The activist investor continues to hold 3,862,116 shares. Separately, Jana settled cash-settled derivative swaps with reference termination dates in April and September 2026. TreeHouse Food…
Select Water Solutions President and CEO John Schmitz sold Class A common shares totaling roughly $661,026 across two transactions in early February. The trades were carried out under a pre-arranged 10b5-1 plan. Separately, the company declared a quarterly cash dividend and disclosed a tax-withholding share disposition tied to equity compensation. …
Zentalis Pharmaceuticals CEO Julia Marie Eastland sold 8,755 shares of common stock via automatic transactions on February 6 and 9, 2026, to cover tax withholding tied to vested restricted stock units. The trades totaled $21,239 at prices between $2.3929 and $2.4297. The company recently halted active development of azenosertib for uterine serous c…
Zentalis Pharmaceuticals Chief Medical Officer Ingmar Bruns executed two automatic sales of company common stock totaling $7,998 in early February 2026 to satisfy tax withholding obligations tied to vested restricted stock units. The transactions took place on February 6 and February 9, 2026, at prices between $2.3929 and $2.4297 per share. Separat…
